Canaccord Raises 10x Genomics Price Target to $100 From $60
Canaccord Genuity raised its price target on 10x Genomics to $100 per share from $60.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.